Posted in M&A / Deals UPDATE: Kailera breaks biotech IPO record with $625M debut April 17, 2026 BioSpace Obesity-focused Kailera Therapeutics debuted on the Nasdaq Friday after raising a record $625 million, beating Moderna’s $600 million from 2018. M&A / DealsRead full story